Four key directives from the Biden administration

President Biden issues executive orders setting new standards for AI safety and security, protecting Americans’ privacy, defending fairness and civil rights, advocating for consumers and workers, and promoting innovation and competition. did.

People’s reactions to AI vary in terms of reliability and output bias. Many Americans are concerned about the role of AI in healthcare, according to a Pew Research survey. Sixty percent of U.S. adults say they would be uncomfortable with healthcare providers using artificial intelligence for tasks such as diagnosing diseases and recommending treatments. In contrast, only 39% said they felt safe.

Below are four directives that impact healthcare.

HHS AI Task Force – One year after the establishment of the task force, the committee will develop a strategic plan with appropriate guidance. This plan includes policies and frameworks that may integrate regulatory measures where appropriate. The focus will be on the responsible implementation and use of AI and AI-enabled technologies in the health and human services sector, spanning research and discovery, drug and device safety, healthcare delivery and financing, and public health.

AI equity – Executive Order calls for principles of equity in AI-enabled technologies in the health and human services sector. This includes using detailed disaggregated data on affected populations and representative population datasets when developing new models. The directive states that the performance of algorithms will be actively monitored to check for discrimination and bias in existing models. It works to identify and reduce discrimination and bias in the current system.

AI security – This directive mandates the integration of safety, privacy, and security standards throughout the software development lifecycle with the specific purpose of protecting personally identifiable information.

AI monitoring – This Executive Order directs the development, maintenance, and use of predictive and generative AI-enabled technologies in health care delivery and financing. This includes quality measurement, performance improvement, program integrity, benefits management, and patient experience. It stipulates that these activities must include considerations such as ensuring adequate human oversight of the application of AI-generated output.

what’s next

Companies will comply with the requirement to share AI safety test results, but will argue that doing so does not protect their intellectual property. Companies are likely to devise strategies to claim compliance with current requirements, often resulting in more red tape than achieving the detailed goals of the regulation. We recognize the challenges that AI poses, but the industry is struggling to find solutions.

Punit Soni, CEO of Suki AI, said, “This executive order is a much-needed and sensible step to demonstrate that AI is front and center of the administration. It outlines several principles that should be front and center for AI companies. However, “there are some flaws. Today’s technology will be tomorrow’s bet. Regulations such as size-based decisions are useless and run the risk of creating onerous requirements, especially for smaller businesses. What should you consider?” There is detailed guidance on usage, infrastructure, training data, and how to address bias, model leakage, and other factors in a way that promotes safety, national security, and equity while preventing regulatory capture. It is essential that these committees and task forces are populated with industry representatives who represent the vibrant startup AI ecosystem, not just the companies that can afford to lobby. ”

James Wellman, healthcare CIO for Nathan Littauer Hospital and Nursing Home, is concerned about the executive order’s potential impact on pricing of AI products. “The EO requires HHS to create a regulatory division that can monitor new AI tools, review them before they are released, and track their performance and outcomes after use,” Wellman said. “We understand that the purpose is to prevent the development of harmful practices.” However, I am concerned about the impact on the market’s ability to react quickly and the price differentials that would put the technology out of reach for hospitals in smaller markets due to cost. The healthcare market is highly attractive and allows us to provide better care to patients, families, and residents. But can we afford it?”

Leading technology companies are focused on harnessing the potential of AI to sharpen clinical judgment, reduce administrative tasks, and provide life-saving predictive capabilities. Time will tell the effectiveness of this executive order in achieving quick results. As AI technology rapidly advances, pressing questions remain. Will regulation be able to keep up in the ever-evolving technological landscape?

follow me twitter Or LinkedIn. check out my website.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *